Chembio secures FDA EUA authorization for Ebola virus diagnostic test
Point-of-care diagnostics firm Chembio Diagnostics has secured emergency use authorization from the US Food and Drug Administration (FDA)…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Nov 18
Point-of-care diagnostics firm Chembio Diagnostics has secured emergency use authorization from the US Food and Drug Administration (FDA)…
08 Nov 18
Integrated healthcare provider Primary Health Care has collaborated with Siemens Healthineers to deploy more than 70 Atellica Solution…
08 Nov 18
Stratec Consumables, a subsidiary of Stratec Biomedical, and NetScientific portfolio firm Vortex BioSciences have entered into a supply…
05 Nov 18
Global Kinetics has said that its PKG smartwatch provides clinically meaningful improvement in Parkinson’s Disease (PD) symptom assessment,…
01 Nov 18
OpGen has partnered with QIAGEN to advance rapid diagnostics for antimicrobial resistance (AMR).
31 Oct 18
CellProThera and BioCardia have partnered for clinical trial and marketing in Singapore of early stem cell therapy for…
31 Oct 18
Point-of-care (POC) tests developer RPS Diagnostics has received updated CE Mark for its FebriDx test to allow incorporation…
31 Oct 18
Illumina has launched TruSight Oncology 500 (TSO 500) pan-cancer assay to power comprehensive, accurate, pan-cancer tumor profiling.
26 Oct 18
Candesant Biomedical has announced positive initial safety and efficacy data from its STAYDRi.1 trial on CDX-101, a new…
25 Oct 18
Debiopharm Group member GenePOC has secured approval from Health Canada and launched its GenePOC CDiff assay for use…